Cytostatic effect on cancer cells

A cytostatic effect refers to the pharmacological outcome where cell growth and multiplication are inhibited without the direct induction of cell death, a process known as cytotoxicity (NCI Dictionary of Cancer Terms, NIH). Unlike traditional cytotoxic agents that kill cells via apoptosis or necrosis, cytostatic agents typically induce cell cycle arrest at specific checkpoints, effectively preventing tumor progression and stabilizing the disease (PubMed: 22843492). This effect is characteristic of various targeted therapies, including cyclin-dependent kinase (CDK4/6) inhibitors and endocrine therapies, which are used to manage hormone-responsive cancers by limiting proliferative signaling (StatPearls: Cancer Chemotherapy). Because the malignant cells remain viable but dormant, the primary therapeutic challenge is the potential for tumor regrowth or the development of resistance upon cessation of treatment. As a phenotypic description of drug action rather than a specific protein or receptor, a cytostatic effect represents a clinical goal or therapeutic strategy rather than a distinct molecular target.

Other names

CytostasisGrowth inhibitionAntiproliferative effectCell cycle arrestTumor stabilization

Cytostatic agents inhibit cell growth and division primarily by inducing cell cycle arrest at specific phases (e.g., G0/G1) or by interfering with mitogenic signaling pathways, rather than by causing direct cell death through apoptosis or necrosis.